Coherus Oncology, Inc.
US ˙ NasdaqGM ˙ US19249H1032

SecurityCHRS / Coherus Oncology, Inc.
InstitutionKnott David M
Latest Disclosed Ownership102,555 shares
Latest Disclosed Value $ 1,648,000
Knott David M reports 2.91% increase in ownership of CHRS / Coherus Oncology, Inc.

On November 12, 2021 - Knott David M filed a 13F-HR form disclosing ownership of 102,555 shares of Coherus Oncology, Inc. (US:CHRS) valued at $1,648,059 USD as of September 30, 2021. The entity filed a previous 13F-HR on August 13, 2021 disclosing 99,655 shares of Coherus Oncology, Inc.. This represents a change in shares of 2.91% during the quarter. The current value of the position is $148,705 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2021-11-12 2021-09-30 13F Coherus Biosciences Common 19249H103 102,555 2,900 2.91 1,648 19.59 0.5988
2021-08-13 2021-06-30 13F Coherus Biosciences Common 19249H103 99,655 0 0.00 1,378 -5.36 0.4898
2021-05-13 2021-03-31 13F Coherus Biosciences Common 19249H103 99,655 -2,000 -1.97 1,456 -17.60 0.6229
2021-02-12 2020-12-31 13F Coherus Biosciences Common 19249H103 101,655 2,162 2.17 1,767 -3.18 0.7996
2020-11-13 2020-09-30 13F Coherus Biosciences Common 19249H103 99,493 -5,073 -4.85 1,825 -2.30 1.0708
2020-08-12 2020-06-30 13F Coherus Biosciences Common 19249H103 104,566 37,527 55.98 1,868 71.85 1.0197
2020-05-13 2020-03-31 13F Coherus Biosciences Common 19249H103 67,039 -8,675 -11.46 1,087 -20.25 0.6860
2020-02-14 2019-12-31 13F Coherus Biosciences Common 19249H103 75,714 12,327 19.45 1,363 6.15 0.5525
2019-11-12 2019-09-30 13F Coherus Biosciences Common 19249H103 63,387 1,000 1.60 1,284 -6.89 0.5394
2019-08-12 2019-06-30 13F Coherus Biosciences Common 19249H103 62,387 21,918 54.16 1,379 149.82 0.5817
2019-05-13 2019-03-31 13F Coherus Biosciences Common 19249H103 40,469 100 0.25 552 51.23 0.2200
2019-02-12 2018-12-31 13F Coherus Biosciences Common 19249H103 40,369 0 0.00 365 -45.20 0.1715
2018-11-13 2018-09-30 13F Coherus Biosciences Common 19249H103 40,369 49 0.12 666 18.09 0.2161
2018-08-13 2018-06-30 13F Coherus Biosciences Common 19249H103 40,320 0 0.00 564 26.46 0.2114
2018-05-11 2018-03-31 13F Coherus Biosciences Common 19249H103 40,320 2,000 5.22 446 32.34 0.1838
2018-02-13 2017-12-31 13F Coherus Biosciences Common 19249H103 38,320 4,000 11.66 337 -26.42 0.1340
2017-11-13 2017-09-30 13F Coherus Biosciences Common 19249H103 34,320 12,000 53.76 458 43.13 0.1958
2017-08-11 2017-06-30 13F Coherus Biosciences Common 19249H103 22,320 22,320 320 0.1336
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.